quinazolines has been researched along with Lower Urinary Tract Symptom in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (87.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bernikov, AN; Loran, OB; Pushkar, DY | 1 |
| Demirtas, A; Keske, M; Sonmez, G; Topaloglu, US | 1 |
| Dahm, P; Jung, JH; Kim, J; Kim, MH; MacDonald, R; Reddy, B | 1 |
| Cheon, J; Choi, JB; Choo, SH; Chung, BH; Kim, HJ; Kim, SW; Kim, TW; Lee, JY; Lee, KS; Lee, SW; Oh, SJ; Park, JK; Park, K; Seong, DH; Shim, KH | 1 |
| Chen, Y; Jian, Z; Li, H; Liao, B; Liu, Q; Wang, K; Yang, T | 1 |
| Miernik, A; Praus, F | 1 |
| Chung, JH; Han, JH; Jo, JK; Kang, DH; Kim, TH; Lee, JW; Lee, JY; Lee, KS; Lee, SH; Lee, SW | 1 |
| Cho, HJ; Cho, JM; Kang, JY; Moon, HS; Seo, DY; Shin, SC; Sung, LH; Yoo, TK; Yu, JH | 1 |
| Aktas, BK; Baykam, MM; Bulut, S; Deren, T; Gokkaya, CS; Memis, A; Ozden, C; Tagci, S | 1 |
| Elsheikh, MG; Salah Azab, S | 1 |
| Altay, AB; Apaydin, E; Bademkiran, F; Cikili, N; Semerci, MB; Turna, B; Umul, M | 1 |
| Chung, WS; Hyun, JS; Kim, SW; Lee, SW; Min, KS; Moon, DG; Moon, KH; Park, JK; Park, K; Ryu, JK; Yang, DY; Yang, SK; Zhang, LT | 2 |
| Feng, ZJ; Zhou, Q; Zhu, LL | 1 |
| Gao, Y; Liu, S; Pang, Z; Yang, X; Yu, Y | 1 |
| Chang, HC; Chen, CS; Chen, WH; Chiang, PH; Chu, SH; Hwang, TI; Lee, LM; Lin, MS; Yeh, SD | 1 |
3 review(s) available for quinazolines and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Randomized Controlled Trials as Topic; Urological Agents | 2017 |
Combination of solifenacin and tamsulosin may provide additional beneficial effects for ureteral stent-related symptoms-outcomes from a network meta-analysis.
Topics: Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Network Meta-Analysis; Pain; Quinazolines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Stents; Tamsulosin; Treatment Outcome; Urinary Catheterization; Urological Agents | 2019 |
[LUTS in BPH patients : Comparison of silodosin versus tamsulosin, naftopidil, alfuzosin and placebo for the treatment of lower urinary tract symptoms].
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Tamsulosin; Treatment Outcome; Urological Agents | 2019 |
4 trial(s) available for quinazolines and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Evaluation of patient outcome after discontinuation of alfuzosin treatment for benign prostatic hyperplasia: a multicentre, prospective study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Lower Urinary Tract Symptoms; Male; Prospective Studies; Prostatic Hyperplasia; Quinazolines; Treatment Outcome; Urodynamics | 2013 |
Comparison of alfuzosin 10 mg with or without propiverine 10 mg, 20 mg in men with lower urinary tract symptom and an overactive bladder: randomised, single-blind, prospective study.
Topics: Benzilates; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Quinazolines; Single-Blind Method; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2014 |
Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive med
Topics: Aged; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Humans; Hypertension; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Quinazolines; Urological Agents | 2015 |
Decreased urinary glycosaminoglycan excretion following alfuzosin treatment on ureteral stent-related symptoms: a prospective, randomized, placebo-controlled study.
Topics: Adult; Double-Blind Method; Female; Glycosaminoglycans; Hematuria; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Quinazolines; Sexual Dysfunction, Physiological; Stents; Surveys and Questionnaires; Syndrome; Treatment Outcome; Ureter; Ureteral Calculi; Ureteral Diseases; Ureteroscopy; Urinary Bladder; Urological Agents | 2016 |
9 other study(ies) available for quinazolines and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
[The influence of alfuzosin monotherapy on the sexual function of patients with benign prostatic hyperplasia in real clinical practice (results of a Russian multicenter study)].
Topics: Adrenergic alpha-Antagonists; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Quality of Life; Quinazolines; Sexual Dysfunction, Physiological; Treatment Outcome | 2022 |
Efficacy of Alfuzosin in Male Patients with Moderate Lower Urinary Tract Symptoms: Is Metabolic Syndrome a Factor Affecting the Outcome?
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Quinazolines; Severity of Illness Index; Treatment Outcome | 2020 |
Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms.
Topics: Adrenergic alpha-Antagonists; Aged; Autonomic Nervous System; Heart Rate; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Quinazolines; Urination; Urodynamics; Urological Agents | 2018 |
Effects of medical therapy or surgery on prostatic and bladder resistive indices in patients with benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatectomy; Prostatic Hyperplasia; Quinazolines; Recovery of Function; Time Factors; Treatment Outcome; Ultrasonography, Doppler; Urinary Bladder; Urodynamics; Urological Agents | 2015 |
The impact of the bladder wall thickness on the outcome of the medical treatment using alpha-blocker of BPH patients with LUTS.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Hyperplasia; Quinazolines; Treatment Outcome; Urinary Bladder; Urodynamics | 2015 |
The relationship between lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: the role of autonomic hyperactivity.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Autonomic Nervous System; Blood Glucose; Body Mass Index; Erectile Dysfunction; Humans; Lipids; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Risk Factors; Sulfonamides; Tamsulosin; Testosterone | 2014 |
Personalized therapeutics of α₁-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Topics: Antihypertensive Agents; Humans; Hypertension; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Quinazolines; Urological Agents | 2015 |
Authors' reply.
Topics: Antihypertensive Agents; Humans; Hypertension; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Quinazolines; Urological Agents | 2015 |
Impact of alfuzosin on sexual function in Taiwanese men with benign prostatic hyperplasia.
Topics: Aged; Drug Administration Schedule; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Sexual Dysfunction, Physiological; Taiwan; Treatment Outcome | 2012 |